Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT01586962 | Warming Sensation Intensity and Acceptability of the Flavour, Local Tolerability of Paracetamol 500 mg + Pseudoephedrine 30 mg Syrup in Patients Suffering a URTI | PHASE3 | COMPLETED | 56 | — | — | May 1, 2012 | May 1, 2012 | Aug 7, 2013 | 1 | Canada |
Intensity of warming sensation felt by subjects between predose to 1 minute postdose where 0 = no warming sensation and 100 = strongest possible warming sensation
| Arm | Type | Description |
|---|---|---|
| Upper Respiratory Infections | EXPERIMENTAL | - |
| Name | Type | Description |
|---|---|---|
| IFF flavor 316 282, Paracetamol, Pseudoephedrine | DRUG | Single dose syrup containing a warmingflavor IFF 316282 in a syrup containing Paracetamol and pseudoephedrine |
Inclusion Criteria: * Subject must have one or more symptoms per category (see also screening assessment of cold symptoms, section 6.1): * mild to moderate body pain, headache, fever or sore throat * nasal congestion (blocked nose) with or without rhinorrhea (runny nose) or sneezing Exclusion Crit...